NephroGenex Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
NephroGenex (NRX) Misses Q2 EPS by 16c
August 12, 2015 4:47 PM EDTNephroGenex (NASDAQ: NRX) reported Q2 EPS of ($0.72), $0.16 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on NephroGenex (NRX) click here.
... More
